Call 516-266-9110 for information
Call 516-266-9110 for information
Spravato is an intranasal form of ketamine that is FDA-approved for the treatment of depression. Spravato has been shown to have a 75% success rate for improving depressive symptoms as compared to 33% with traditional antidepressants.
If you are an adult suffering with depression and have tried at least 2 antidepressants at moderate doses for 4 to 6 weeks or longer, you might be a candidate for Spravato treatment.
Spravato works on glutamate receptors in the brain that help to produce new neural pathways. This is a novel approach in treating depression.
Spravato is an FDA approved medication that is safe and effective for treatment of resistant depression. Spravato is not used for patients with:
Yes! We accept most commercial insurances and Medicare. We do not accept Medicaid plans.
After Spravato is administered, you will need to be monitored for 2 hours. Treatment will occur twice per week for the first 4 weeks, then once per week for the next 4 weeks, and then as needed, usually once every 1 to 3 months. You will require a ride home from a friend or family member.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.